Blair William & Co. IL Decreases Position in The Clorox Company (NYSE:CLX)

Blair William & Co. IL decreased its stake in The Clorox Company (NYSE:CLX) by 4.8% in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 8,807 shares of the company’s stock after selling 445 shares during the quarter. Blair William & Co. IL’s holdings in Clorox were worth $1,202,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of CLX. Corient Private Wealth LLC raised its position in Clorox by 7.1% in the 4th quarter. Corient Private Wealth LLC now owns 33,570 shares of the company’s stock worth $4,787,000 after purchasing an additional 2,230 shares during the period. Cambridge Investment Research Advisors Inc. raised its holdings in shares of Clorox by 1.0% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 48,102 shares of the company’s stock worth $6,859,000 after buying an additional 498 shares during the period. Hilltop Holdings Inc. lifted its stake in shares of Clorox by 17.3% during the 4th quarter. Hilltop Holdings Inc. now owns 2,813 shares of the company’s stock worth $401,000 after acquiring an additional 415 shares during the last quarter. Parallel Advisors LLC boosted its holdings in Clorox by 10.0% during the 4th quarter. Parallel Advisors LLC now owns 3,887 shares of the company’s stock valued at $554,000 after acquiring an additional 354 shares during the period. Finally, Mitchell Sinkler & Starr PA bought a new position in Clorox in the 4th quarter valued at $525,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CLX. Citigroup lifted their target price on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. DA Davidson reaffirmed a “neutral” rating and set a $153.00 target price on shares of Clorox in a research report on Friday, September 6th. TD Cowen began coverage on Clorox in a report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price target for the company. Finally, Argus raised Clorox to a “hold” rating in a research note on Tuesday, June 4th. Six research analysts have rated the stock with a sell rating and twelve have issued a hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $143.33.

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.51% of the stock is owned by insiders.

Clorox Trading Down 0.2 %

NYSE:CLX opened at $164.53 on Wednesday. The stock has a market capitalization of $20.43 billion, a price-to-earnings ratio of 85.25, a PEG ratio of 3.29 and a beta of 0.40. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.09. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The firm has a 50 day moving average of $150.33 and a 200 day moving average of $143.83.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. The firm had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. As a group, sell-side analysts anticipate that The Clorox Company will post 6.63 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.97%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.